119 related articles for article (PubMed ID: 1965941)
1. Mechanism for antagonism of paraoxon by hemicholinium-3 analogues.
Bhattacharyya B; Sokoll MD; Flynn JR; Nyanda AM; Lee T; Cannon JG; Long JP
Arch Int Pharmacodyn Ther; 1990; 308():149-67. PubMed ID: 1965941
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular blocking action of two hemicholinium-3 analogs.
Bhattacharyya B; Sokoll MD; Cannon JG; Long JP
Eur J Pharmacol; 1988 Jan; 146(1):155-65. PubMed ID: 2832194
[TBL] [Abstract][Full Text] [Related]
3. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
Maleque MA; Souccar C; Cohen JB; Albuquerque EX
Mol Pharmacol; 1982 Nov; 22(3):636-47. PubMed ID: 6296656
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
Warnick JE; Maleque MA; Bakry N; Eldefrawi AT; Albuquerque EX
Mol Pharmacol; 1982 Jul; 22(1):82-93. PubMed ID: 6126806
[TBL] [Abstract][Full Text] [Related]
5. Endplate channel actions of a hemicholinium-3 analog, DMAE.
Alkadhi KA
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):230-5. PubMed ID: 3012371
[TBL] [Abstract][Full Text] [Related]
6. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. I. Blockade of the ionic channel.
Souccar C; Varanda WA; Daly JW; Albuquerque EX
Mol Pharmacol; 1984 May; 25(3):384-94. PubMed ID: 6328264
[TBL] [Abstract][Full Text] [Related]
7. Prevention of organophosphate-induced toxicity in mice.
Ozkutlu U; Long JP; Cannon JG; Sahin MF; Liang C
Arch Int Pharmacodyn Ther; 1995; 329(2):331-42. PubMed ID: 8540771
[TBL] [Abstract][Full Text] [Related]
8. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
Ikeda SR; Aronstam RS; Daly JW; Aracava Y; Albuquerque EX
Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884
[TBL] [Abstract][Full Text] [Related]
9. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
Pascuzzo GJ; Akaike A; Maleque MA; Shaw KP; Aronstam RS; Rickett DL; Albuquerque EX
Mol Pharmacol; 1984 Jan; 25(1):92-101. PubMed ID: 6323955
[TBL] [Abstract][Full Text] [Related]
10. Hemicholinium-3 and related ether analogues on the synthesis of acetylcholine by mouse brain (in vitro).
Bove FC; Haarstad VB
Arch Int Pharmacodyn Ther; 1981 Oct; 253(2):278-93. PubMed ID: 7325764
[TBL] [Abstract][Full Text] [Related]
11. Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor.
Rao KS; Aracava Y; Rickett DL; Albuquerque EX
J Pharmacol Exp Ther; 1987 Jan; 240(1):337-44. PubMed ID: 2433427
[TBL] [Abstract][Full Text] [Related]
12. Hemicholinium-3 congeners as potential antagonists to organophosphate-induced toxicity.
Cannon JG; Sahin MF; Long JP; Flynn JR; Bhatnagar RK
J Med Chem; 1990 Feb; 33(2):577-9. PubMed ID: 2153818
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of clindamycin and lincomycin on end-plate currents and quantal content at the neuromuscular junction.
Fiekers JF; Henderson F; Marshall IG; Parsons RL
J Pharmacol Exp Ther; 1983 Nov; 227(2):308-15. PubMed ID: 6313896
[TBL] [Abstract][Full Text] [Related]
14. Interactions of edrophonium, physostigmine and methanesulfonyl fluoride with the snake end-plate acetylcholine receptor-channel complex.
Fiekers JF
J Pharmacol Exp Ther; 1985 Sep; 234(3):539-49. PubMed ID: 2411911
[TBL] [Abstract][Full Text] [Related]
15. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex.
Shaw KP; Aracava Y; Akaike A; Daly JW; Rickett DL; Albuquerque EX
Mol Pharmacol; 1985 Dec; 28(6):527-38. PubMed ID: 2417099
[TBL] [Abstract][Full Text] [Related]
16. Interaction of analogs of histrionicotoxin with the acetylcholine receptor ionic channel complex and membrane excitability.
Maleque MA; Brossi A; Witkop B; Godleski SA; Albuquerque EX
J Pharmacol Exp Ther; 1984 Apr; 229(1):72-9. PubMed ID: 6323691
[TBL] [Abstract][Full Text] [Related]
17. The effects of chloramphenicol isomers on the motor end-plate nicotinic receptor-ion channel complex.
Henderson F; Prior C; Dempster J; Marshall IG
Mol Pharmacol; 1986 Jan; 29(1):52-64. PubMed ID: 2418348
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship studies in the hemicholinium ('HC-3') series.
Cannon JG; Lee TM; Nyanda AM; Bhattacharyya B; Long JP
Drug Des Deliv; 1987 Feb; 1(3):209-18. PubMed ID: 2855565
[TBL] [Abstract][Full Text] [Related]
19. Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes.
Spivak CE; Maleque MA; Oliveira AC; Masukawa LM; Tokuyama T; Daly JW; Albuquerque EX
Mol Pharmacol; 1982 Mar; 21(2):351-61. PubMed ID: 6285171
[TBL] [Abstract][Full Text] [Related]
20. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist.
Varanda WA; Aracava Y; Sherby SM; VanMeter WG; Eldefrawi ME; Albuquerque EX
Mol Pharmacol; 1985 Aug; 28(2):128-37. PubMed ID: 2410768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
